ASX - By Stock
|
IMU |
Re:
Q, What are the details and price of the next C R
|
|
Mangoman605
|
26 |
7.6K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
26
|
7.6K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mangoman605
|
24K |
11M |
7 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mangoman605
|
24K |
11M |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
24K
|
11M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Mangoman605
|
49 |
17K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
49
|
17K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Mangoman605
|
49 |
17K |
5 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
49
|
17K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
0 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
495
|
172K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
News: NXS Next Science Sees FY24 To Deliver Significant Topline Growth Across 3 Key Areas Of...
|
|
Mangoman605
|
6 |
3.2K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
6
|
3.2K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
FDA approval timeline and follow up timeline
|
|
Mangoman605
|
6 |
2.0K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
6
|
2.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
FDA approval timeline and follow up timeline
|
|
Mangoman605
|
6 |
2.0K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
6
|
2.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
Mangoman605
|
52 |
17K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
17K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
Mangoman605
|
52 |
17K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
17K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Mangoman605
|
117 |
48K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
48K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Mangoman605
|
117 |
48K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
117
|
48K
|
4
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Mangoman605
|
117 |
48K |
8 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
117
|
48K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Shareholders got stooged from AFL hype
|
|
Mangoman605
|
11 |
4.9K |
1 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
11
|
4.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Shareholders got stooged from AFL hype
|
|
Mangoman605
|
11 |
4.9K |
1 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
11
|
4.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mangoman605
|
34 |
16K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
16K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mangoman605
|
34 |
16K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
16K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Mangoman605
|
92 |
39K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
39K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
495
|
172K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
495
|
172K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
495
|
172K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
6 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
495
|
172K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
2 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
495
|
172K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Preliminary results of further XPERIENCE studies released
|
|
Mangoman605
|
9 |
3.1K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
9
|
3.1K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
30
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
30
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
30
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
30
|
11K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
12 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
30
|
11K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Mangoman605
|
30 |
11K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
30
|
11K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
495
|
172K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
7 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
495
|
172K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
495
|
172K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
495
|
172K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
495
|
172K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
495
|
172K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
16 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
495
|
172K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
495
|
172K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
15 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
495
|
172K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mangoman605
|
24K |
11M |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
24K
|
11M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Mangoman605
|
495 |
172K |
12 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
495
|
172K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
Mangoman605
|
54 |
17K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
17K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Mangoman605
|
19 |
8.1K |
0 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
19
|
8.1K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Mangoman605
|
19 |
8.1K |
6 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
19
|
8.1K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Mangoman605
|
19 |
8.1K |
0 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
19
|
8.1K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Mangoman605
|
19 |
8.1K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
19
|
8.1K
|
5
|
|